These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1186921)

  • 1. Effect of nafenopin (SU-13,437) on liver function: mechanism of choleretic effect.
    Levine WG; Braunstein HR; Mejier DK
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):221-34. PubMed ID: 1186921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nafenopin (SU-13,437) on liver functions. Hepatic uptake and biliary excretion of ouabain in the rat.
    Meijer DK; Bognacki J; Levine WG
    Drug Metab Dispos; 1975; 3(3):220-5. PubMed ID: 238821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nafenopin (SU-13,437) on liver function: influence on the hepatic transport of organic anions.
    Meijer DK; Bognacki J; Levine WG
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):235-50. PubMed ID: 810733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nafenopin (SU-13437) on liver function. Influence on the hepatic transport of phenolphthalein glucuronide and chlorothiazide.
    Uesugi T; Levine WG
    Drug Metab Dispos; 1976; 4(2):107-11. PubMed ID: 5253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some biochemical changes associated with nafenopin-induced liver growth in the rat.
    Levine WG; Ord MG; Stocken LA
    Biochem Pharmacol; 1977 May; 26(10):939-42. PubMed ID: 861041
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary excretion of 3,4-benzpyrene in nafenopin-treated rats.
    Levine WG; Bognacki J
    J Pharmacol Exp Ther; 1976 Feb; 196(2):486-92. PubMed ID: 1255492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent ATP-dependent transport across the canalicular membrane.
    Jedlitschky G; Leier I; Böhme M; Buchholz U; Bar-Tana J; Keppler D
    Biochem Pharmacol; 1994 Sep; 48(6):1113-20. PubMed ID: 7945404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choleretic effect of valproic acid in the rat.
    Watkins JB; Klaassen CD
    Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The choleretic effect of iodipamide.
    Feld GK; Loeb PM; Berk RN; Wheeler HO
    J Clin Invest; 1975 Mar; 55(3):528-35. PubMed ID: 1117066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the hypolipidemic drug nafenopin (2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy)propionic acid; TPIA; SU-13,437), on the hepatic disposition of foreign compounds in the rat.
    Levine WG
    Drug Metab Dispos; 1974; 2(2):178-86. PubMed ID: 4150998
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible mechanism of choleretic action of 3-(2,4,5-triethoxybenzoyl)-propionic acid (AA-149) in dogs.
    Satoh H; Kanno M; Maki Y
    Eur J Pharmacol; 1978 Mar; 48(1):125-32. PubMed ID: 639840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile-salt-dependent and independent choleresis induced by bucolome in the rat.
    Kitani K; Morita Y; Miura R; Kanai S
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1155-61. PubMed ID: 21733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on increased bile formation produced by polyoxybenzenes in rats.
    Tanayama S; Kanai Y
    Jpn J Pharmacol; 1977 Feb; 27(1):71-8. PubMed ID: 864884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choleretic mechanisms of sodium taurocholate, secretin, and glucagon.
    Russell TR; Searle GL; Jones RS
    Surgery; 1975 Apr; 77(4):498-504. PubMed ID: 1145427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of y and z protein.
    Meijer DK; Vonk RJ; Keulemans K; Weitering JG
    J Pharmacol Exp Ther; 1977 Jul; 202(1):8-21. PubMed ID: 874820
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of butylated hydroxytoluene (BHT) on biliary excretion of xenobiotics and bile flow in rats.
    Choe SY; Kim HM; Yang KH
    Drug Chem Toxicol; 1984; 7(2):149-65. PubMed ID: 6434281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism and morphologic changes in the liver of nafenopin-treated rats.
    Tuchweber B; Kourounakis P; Latour JG
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):309-21. PubMed ID: 984981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nafenopin on the uptake of bilirubin and sulfobromophthalein by isolated perfused rat liver.
    Gärtner U; Stockert RJ; Levine WG; Wolkoff AW
    Gastroenterology; 1982 Dec; 83(6):1163-9. PubMed ID: 6751925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of pyrimidine and nucleic acid synthesis during adaptive growth of liver induced by nafenopin, a peroxisome proliferator. An in vivo study.
    Seifert J; Mostecká H
    Carcinogenesis; 1989 Aug; 10(8):1383-8. PubMed ID: 2473851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An osmotic explanation for valproic acid induced choleresis in the rat, dog and monkey.
    Dickinson RG; Harland RC; Kaufman SN; Lynn RK; Gerber N
    Arzneimittelforschung; 1982; 32(3):241-7. PubMed ID: 6805484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.